(BCAT) BlackRock Capital - Ratings and Ratios
Investment Management, Custody Services
BCAT EPS (Earnings per Share)
BCAT Revenue
Description: BCAT BlackRock Capital
BlackRock Capital Allocation Trust (BCAT) is a closed-end investment company that is listed on the New York Stock Exchange. As a member of the Asset Management & Custody Banks sub-industry, BCATs primary objective is to provide shareholders with a stable source of income and long-term capital appreciation through a diversified portfolio of investments.
Analyzing the trusts recent price action, we observe a relatively stable trend, with the stock price hovering around $14.75. The short-term moving averages (SMA20: $14.73, SMA50: $14.24) indicate a gentle upward trajectory, suggesting a potential continuation of the current trend. The Average True Range (ATR) of 0.17, equivalent to 1.17%, implies a moderate level of volatility.
From a fundamental perspective, BCATs market capitalization stands at $1.586 billion, with a price-to-earnings ratio of 8.32, indicating a relatively undervalued position compared to its peers. The trusts return on equity (RoE) of 10.60% suggests a decent level of profitability. However, the absence of a forward P/E ratio makes it challenging to gauge the markets expectations for future earnings growth.
Using a combination of technical and fundamental analysis, we can forecast a potential price target for BCAT. Assuming the current trend continues, and considering the trusts relatively low valuation and decent profitability, we can estimate a potential price increase to $15.50 over the next 6-12 months. This forecast is based on the convergence of the short-term moving averages and the trusts historical price range, as well as its fundamental characteristics, such as market capitalization and return on equity.
To validate this forecast, we will continue to monitor BCATs price action, moving averages, and fundamental metrics, making adjustments as necessary to ensure an optimal investment outcome.
BCAT Stock Overview
| Market Cap in USD | 1,567m |
| Sector | Financial Services |
| Industry | Asset Management |
| GiC Sub-Industry | Asset Management & Custody Banks |
| IPO / Inception | 2020-09-25 |
BCAT Stock Ratings
| Growth Rating | 33.7 |
| Fundamental | 52.4% |
| Dividend Rating | 94.4 |
| Rel. Strength | -7.05 |
| Analysts | - |
| Fair Price Momentum | 20.01 USD |
| Fair Price DCF | 107.42 USD |
BCAT Dividends
| Dividend Yield 12m | 23.70% |
| Yield on Cost 5y | 29.42% |
| Annual Growth 5y | 91.11% |
| Payout Consistency | 82.5% |
| Payout Ratio | 153.5% |
BCAT Growth Ratios
| Growth Correlation 3m | 89.4% |
| Growth Correlation 12m | 65.4% |
| Growth Correlation 5y | 33.4% |
| CAGR 5y | 5.49% |
| CAGR/Max DD 5y | 0.15 |
| Sharpe Ratio 12m | 1.80 |
| Alpha | 5.26 |
| Beta | 0.499 |
| Volatility | 10.33% |
| Current Volume | 679.9k |
| Average Volume 20d | 569.7k |
| Stop Loss | 14.6 (-3.2%) |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (194.4m TTM) > 0 and > 6% of Revenue (6% = 11.9m TTM) |
| FCFTA 0.18 (>2.0%) and ΔFCFTA 10.40pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| error: NWC/Revenue cannot be calculated (needs Current Assets/Liabilities and Revenue current+prev) |
| CFO/TA 0.18 (>3.0%) and CFO 354.9m > Net Income 194.4m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| error: Current Ratio cannot be calculated (needs Total Current Assets and Liabilities) |
| Outstanding Shares last Quarter (NaN) change vs 12m ago NaN% (target <= -2.0% for YES) |
| Gross Margin 98.35% (prev 0.0%; Δ 98.35pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 9.46% (prev 9.18%; Δ 0.28pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.0 (EBITDA TTM 0.0 / Interest Expense TTM 1.40m) >= 6 (WARN >= 3) |
ValueRay F-Score (Strict, 0-100) 52.38
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield 22.73% = 5.0 |
| 3. FCF Margin data missing |
| 4. Debt/Equity data missing |
| 5. Debt/Ebitda data missing |
| 6. ROIC - WACC 0.0% = 0.0 |
| 7. RoE 10.60% = 0.88 |
| 8. Revenue Trend data missing |
| 9. Revenue CAGR data missing |
| 10. EPS Trend data missing |
| 11. EPS CAGR -89.21% = -2.50 |
As of August 12, 2025, the stock is trading at USD 15.09 with a total of 679,936 shares traded.
Over the past week, the price has changed by +1.07%, over one month by +1.10%, over three months by +5.00% and over the past year by +15.93%.
Neither. Based on ValueRay´s Fundamental Analyses, BlackRock Capital is currently (August 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 52.38 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BCAT is around 20.01 USD . This means that BCAT is currently undervalued and has a potential upside of +32.6% (Margin of Safety).
BlackRock Capital has no consensus analysts rating.
According to our own proprietary Forecast Model, BCAT BlackRock Capital will be worth about 22.2 in August 2026. The stock is currently trading at 15.09. This means that the stock has a potential upside of +46.85%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 22.2 | 46.9% |
BCAT Fundamental Data Overview
CCE Cash And Equivalents = 6.30m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 8.1749
P/S = 8.0403
P/B = 0.9106
Beta = None
Revenue TTM = 197.7m USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
[93m Long Term Debt = unknown (none)
[39m[93m Short Term Debt = unknown (none)
[39m[93m Debt = unknown
[39m Net Debt = -6.30m USD (from netDebt column, last quarter)
Enterprise Value = 1.56b USD (1.57b + (null Debt) - CCE 6.30m)
Interest Coverage Ratio = 0.0 (Ebit TTM 0.0 / Interest Expense TTM 1.40m)
FCF Yield = 22.73% (FCF TTM 354.9m / Enterprise Value 1.56b)
[93m FCF Margin = 179.5% (FCF TTM 354.9m / Revenue TTM 197.7m)
[39m Net Margin = 98.35% (Net Income TTM 194.4m / Revenue TTM 197.7m)
Gross Margin = 98.35% ((Revenue TTM 197.7m - Cost of Revenue TTM 3.25m) / Revenue TTM)
Tobins Q-Ratio = 0.91 (Enterprise Value 1.56b / Book Value Of Equity 1.72b)
[93m Interest Expense / Debt = unknown (Interest Expense 1.40m / Debt none)
[39m Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
[93m Current Ratio = unknown (Total Current Assets 6.30m / Total Current Liabilities none)
[39m[93m Debt / Equity = unknown Debt (none)
[39m[93m Debt / EBITDA = unknown (Net Debt -6.30m / EBITDA 0.0)
[39m[93m Debt / FCF = none (Debt none / FCF TTM 354.9m)
[39m Total Stockholder Equity = 1.83b (last 4 quarters mean)
RoA = 10.10% (Net Income 194.4m, Total Assets 1.92b )
RoE = 10.60% (Net Income TTM 194.4m / Total Stockholder Equity 1.83b)
[93m RoCE = unknown (Ebit 0.0 / (Equity 1.83b + L.T.Debt none))
[39m RoIC = 0.0% (NOPAT 0.0 / Invested Capital 1.87b)
[93m WACC = unknown (E(1.57b)/V(0.0) * Re(7.85%)) + (D(none)/V(0.0) * Rd(none%) * (1-Tc(0.21)))
[39m Shares Correlation 5-Years: 5.10 | Cagr: 1.45%
Discount Rate = 7.85% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 81.58% ; FCFE base≈285.5m ; Y1≈365.2m ; Y5≈676.7m
Fair Price DCF = 107.4 (DCF Value 11.25b / Shares Outstanding 104.8m; 5y FCF grow 30.0% → 2.90% )
EPS Correlation: N/A | EPS CAGR: -89.21%
Additional Sources for BCAT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle